Ahmed Nadim, President and CEO of Cullinan Therapeutics, Inc. ($CGEM), sold shares on the open market three times in the last 365 days for a total of about $518,000. His most recent sale occurred on February 24, 2026. These transactions rank him 6,355th among 11,678 individual insiders by sale value, compared to an average of $8.6 million per insider and about six sales. Nadim made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 13515 | $14.47 | 390,803.0000 | 59,076,259 | 3.34% | 0.02% |
| Feb. 20, 2026 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 16381 | $13.62 | 404,318.0000 | 59,076,259 | 3.89% | 0.03% |
| Feb. 18, 2026 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 828000 | $0.00 | 828,000.0000 | 59,076,259 | 9999.99% | 1.40% |
| Dec. 23, 2025 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 9922 | $10.01 | 420,699.0000 | 59,076,259 | 2.30% | 0.02% |
| July 14, 2025 | Disc Medicine, Inc. | $IRON | AHMED NADIM | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 34,569,042 | 9999.99% | 0.06% |
| Feb. 25, 2025 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 12529 | $8.53 | 430,621.0000 | 58,510,610 | 2.83% | 0.02% |
| Feb. 19, 2025 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 360000 | $0.00 | 360,000.0000 | 58,510,610 | 9999.99% | 0.62% |
| Feb. 19, 2025 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Common Stock | 180000 | $0.00 | 443,150.0000 | 58,510,610 | 68.40% | 0.31% |
| Dec. 24, 2024 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 8400 | $11.87 | 263,150.0000 | 42,900,083 | 3.09% | 0.02% |
| Feb. 22, 2024 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Common Stock | 160000 | $0.00 | 271,550.0000 | 42,900,083 | 143.43% | 0.37% |
| Feb. 22, 2024 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 42,900,083 | 9999.99% | 0.75% |
| Dec. 26, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 4272 | $9.24 | 111,550.0000 | 0 | 3.69% | 0.00% |
| June 28, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 759 | $11.40 | 115,822.0000 | 0 | 0.65% | 0.00% |
| May 23, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 707 | $9.15 | 116,581.0000 | 0 | 0.60% | 0.00% |
| April 25, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 716 | $10.59 | 117,288.0000 | 0 | 0.61% | 0.00% |
| March 23, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | S | Common Stock | 706 | $10.51 | 118,004.0000 | 0 | 0.59% | 0.00% |
| Feb. 22, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Stock Option (Right to Buy) | 211000 | $0.00 | 211,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2023 | Cullinan Therapeutics, Inc. | $CGEM | AHMED NADIM | President and CEO | A | Common Stock | 109000 | $0.00 | 118,710.0000 | 0 | 1122.55% | 0.00% |